Abstract: The present disclosure provides methods and compositions for treating or reducing a dental condition in an animal, particularly in canine and feline companion animals. Compositions useful in the disclosed methods comprise an effective amount of lactic acid. The disclosed compositions may also contain oral health promoting effective amounts of at least one antioxidant. Dental conditions treated or reduced according to the disclosed methods include dental plaque, calculus, tooth staining, halitosis, stomatitis, gingivitis, periodontitis, and combinations thereof.

Abstract: The present invention pertains to compositions and methods useful for treating anemia and other effects that are commonly associated in cancer bearing animals. The invention is accomplished by delivering an effective amount of a nucleic acid expression construct that encodes a GHRH or functional biological equivalent thereof into a tissue of an animal and allowing expression of the encoded gene in the animal.

Abstract: A universal concrete or masonry block with four walls, a hollow center within the four walls, and a recessed knockout panel on each wall. Each recessed knockout panel is half the height of the block and has recessed cutting slots partially through the wall on either side of the recessed panel. The recessed knockout panels may be removed to leave an opening as desired on any or all of the four sides of the block. The opening(s) may be used to support a fence rail, a light or a plant.

Abstract: The present invention pertains to compositions and methods for plasmid-mediated supplementation. The compositions and methods are useful for treating anemia and other effects that are commonly associated in cancer bearing animals. Overall, the embodiments of the invention can be accomplished by delivering an effective amount of a nucleic acid expression construct that encodes a GHRH or functional biological equivalent thereof into a tissue of an animal and allowing expression of the encoded gene in the animal. For example, when such a nucleic acid sequence is delivered into the specific cells of the animal tissue specific constitutive expression is achieved.

Abstract: A composition and method of treating symptoms of diarrhea that utilize administering an effective amount of an isolated calcium aluminosilicate anti-diarrheal (“CASAD”), wherein the isolated CASAD is substantially free from T4-dioxin and toxic heavy metal contamination, waiting a period of time; and repeating the administration of the composition until the symptoms of diarrhea are mitigated. The symptoms of diarrhea may be associated with chronic or infectious diseases, inflammatory proteins, treatment using drugs, or treatment using a chemotheraputic agent in a subject in need of treatment. The isolated CASAD is capable of binding inflammatory proteins, drug metabolites, and chemotherapeutic agents. The isolated CASAD can be administered in any suitable form, such as in tablet, powder, or suspension form, and can be administered by any suitable route, such as orally.

Abstract: The present invention pertains to compositions and methods for plasmid-mediated supplementation. The compositions and method are useful for retarding the growth of the tumor, and retarding cachexia, wasting, anemia and other effects that are commonly associated in cancer bearing animals. Overall, the embodiments of the invention can be accomplished by delivering an effective amount of a nucleic acid expression construct that encodes a GHRH or functional biological equivalent thereof into a tissue of an animal and allowing expression of the encoded. gene in the animal. For example, when such a nucleic acid sequence is delivered into the specific cells of the tissue specific constitutive expression is achieved.

Abstract: The invention generally relates to a latch apparatus having a locking live bolt. One embodiment of the invention is a latch apparatus having a housing with opposed plates that are spaced apart and secured to each other by support arms formed from the plates. A live bolt of the apparatus is slidably mounted in the housing and horizontally actuated between an extended and a retracted position. A live bolt hub is mounted in the housing and actuates the live bolt. A slide, actuated by a rotatable cam, is mounted in the housing and moves vertically between a first position and a second position. In the first position the slide is disengaged from the live bolt, and in the second position the slide locks the live bolt in an extended position.

Abstract: The invention generally relates to a latch apparatus having a locking live bolt. One embodiment of the invention is a latch apparatus having a housing with opposed plates that are spaced apart and secured to each other by support arms formed from the plates. A live bolt of the apparatus is slidably mounted in the housing and horizontally actuated between an extended and a retracted position. A live bolt hub is mounted in the housing and actuates the live bolt. A slide, actuated by a rotatable cam, is mounted in the housing and moves vertically between a first position and a second position. In the first position the slide is disengaged from the live bolt, and in the second position the slide locks the live bolt in an extended position.

Abstract: The present invention pertains to compositions and methods for plasmid-mediated supplementation. The compositions and method are useful for retarding the growth of the tumor, and retarding cachexia, wasting, anemia and other effects that are commonly associated in cancer bearing animals. Overall, the embodiments of the invention can be accomplished by delivering an effective amount of a nucleic acid expression construct that encodes a GHRH or functional biological equivalent thereof into a tissue of an animal and allowing expression of the encoded gene in the animal. For example, when such a nucleic acid sequence is delivered into the specific cells of the animal tissue specific constitutive expression is achieved. Furthermore, external regulation of the GHRH or functional biological equivalent thereof gene can be accomplished by utilizing inducible promoters that are regulated by molecular switch molecules, which are given to the animal.